These findings suggest a significant alteration in the distribution of NK cell subsets in the peripheral blood of ESCC patients, particularly a marked increase in CD3-CD56+ NK cells, which may play a critical role in antitumor immune responses. Here, NCAM1 is linked to esophageal squamous cell carcinoma.